Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine
Clinical trial NCT00722774 · COMPLETED
Trial details
- NCT number
- NCT00722774
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Primary completion
- 2008-09-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.